Page 37 - selçuk bakış 55
P. 37

Tablo: SARS-CoV-2 ve Kalp ile ilişkili komplikasyonlar (1)
                        Hasta                                                  Hastane
           İlk yazar    Sayısı    Kalp ile ilişkili komplikasyonlar  Troponin  mortalitesi


          Huang et al    41                Şok (7%)               Artmış:        %15
                                                                   12.2%
                                         Aritmi (16.7%)
                                                                  Ortanca
          Wang et al     118               Sok (8.7%)            6.4 pg/mL      4.3%

                                    Akut kardiyak hasar (7.2%)
                                       Göğüs ağrısı (3.4%)
           Shi et al    416                                       Artmış:       13.7%
                                                                   19.7%
                                   EKG’de ST depresyon (0.7%)
                                      Kalp yetmezliği (23%)

           Zhou et al    191           Hipotansiyon (1%)          Artmış:       28.2%
                                                                    17%
                                    Kalp hızı > 125 atım/dk (1%)

           Guo et al    187              VT/VF (5.9%)             Artmış:        %23
                                                                   27.8%

        KAYNAKLAR                                 severe progression in COVID-19 patients. Cell
                                                  Mol  Immunol.  2020.  https://doi.org/10.1038/
        1- Kochi AN, Tagliari AP, Forleo GB, Fassini GM,   s41423-020-0401-3.
        Tondo C. Cardiac and arrhythmic complications
        in patients with COVID-19. J Cardiovasc Elect-  6. Zhou F, Yu T, Du R, et al . Clinical course and
        rophysiol. 2020;31(5):1003-1008. doi:10.1111/  risk  factors  for  mortality  of  adult  inpatients
        jce.14479                                 with COVID-19 in Wuhan, China: a retrospec-
                                                  tive cohort study. Lancet 2020 28; 395(10229):
        2- Guo T, Fan Y, Chen M, et al. Cardiovascular   1054–1062.
        implications of fatal outcomes of patients with
        coronavirus disease 2019 (COVID-19).      7. Tang N, Li D, Wang X, Sun Z. Abnormal co-
                                                  agulation parameters are associated with poor
        JAMA  Cardiol.  2020.  https://doi.org/10.1001/  prognosis  in  patients  with  novel  coronavirus
        jamacardio.2020.1017                      pneumonia.  J  Thromb  Haemost.  2020;4:844-
        3. Terpos, E, Ntanasis-Stathopoulos, I, Elalamy,   847.
        I, et al. Hematological findings and complicati-  8. Cheng Y, Luo R, Wang K, et al. Kidney disease
        ons of COVID-19. Am J Hematol. 2020; 1– 14.  is associated with in-hospital death of patients
        https://doi.org/10.1002/ajh.25829         with  COVID-19.  Kidney  Int.  2020;97(5):829-
        4. Guan WJ, Ni ZY, Hu Y, et al. Clinical charac-  838. doi:10.1016/j.kint.2020.03.005
        teristics of coronavirus disease 2019 in China.  9. Hua S, Ming Y, Chen W, Li-Xia Y. Renal histo-
        N Engl J Med. 2020;382(18):1708-1720. https://  pathological analysis of 26 postmortem findin-
        doi.org/10.1056/NEJMoa2002032.            gs of patients with COVID-19 in China Kidney
                                                  Int. 2020;                                                  selçukbakış Sayı’55
        5. Zheng HY, Zhang M, Yang CX, et al. Elevated
        exhaustion levels and reduced functional diver-  10.https://www.kidney.org/coronavirus/kid-
        sity of T cells in peripheral blood may predict  ney-disease-covid-19                            35
   32   33   34   35   36   37   38   39   40   41   42